Plutux
$9.97
+0.25%
2026-09-04 10:14:10 EDT+$0.00
Financial Services
Shell Companies
NASDAQ
Active Trading

Averin Capital Acquisition Corp. (ACAA) functions as a special purpose acquisition company (SPAC), specifically created to pursue a business combination. Its core ...

Price Action

$9.97
+0.00%+$0.00
High
Low
52W High-2.6%
Rel. vol
Interval
Range35m
VolumeSMA5SMA10
Averin Capital Acquisition Corp. (ACAA) is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands on October 17, 2025, with operations headquartered in New York City. The company was formed with the sole purpose of effecting a business combination, which may involve a merger, stock exchange, asset acquisition, ...Averin Capital Acquisition Corp. (ACAA) is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands on October 17, 2025, with operations headquartered in New York City. The company was formed with the sole purpose of effecting a business combination, which may involve a merger, stock exchange, asset acquisition, share purchase, or similar transaction with one or more operating businesses. It focuses on acquiring a company at the intersection of technology and health, leveraging the expertise of its management team and sponsor, Averin Capital LLC, a multi-stage investment firm. The company's CEO, David A. Berry, brings over two decades of experience in healthcare and technology innovation. ACAA completed its initial public offering (IPO) on February 19, 2026, raising $250 million by selling 25 million units at $10.00 per unit. The units began trading on the NASDAQ Global Market under the ticker 'ACAAU', and later the shares and warrants separated. As of the latest data, the company has a market capitalization of approximately $356 million, with a stock price of $9.99. It has minimal operational expenses and negative operating cash flow, typical for a SPAC before a business combination. The company employs only 3 full-time employees, focusing on identifying and executing a target acquisition within the allowed time frame (24 months plus possible extensions). Financial metrics show a price-to-book ratio of ~1.05 and negative enterprise value to EBITDA, reflecting pre-transaction status. The company's goal is to deliver value to shareholders by acquiring high-growth businesses in the health-tech sector, potentially benefiting from secular trends in digital health, biotechnology, and AI-driven medical solutions.
Founded
2025
Employees
3
CEO
David A. Berry
Full Name
Averin Capital Acquisition Corp.
Sector
Financial Services
Industry
Shell Companies
ROE
1.15%
Market Cap
$0.36B
Current Ratio
3.25
ROIC
-122.64%

Contact Information

1 339 234-9160
240 West 40th Street, New York, NY 10018

Related stocksShell Companies

Browse all US stocks

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026